Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs Placebo in ACLF Patients with Small or No Esophageal Varices
NCT02583698Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in acute-on-chronic liver failure (ACLF) comparing Carvedilol Arm with Placebo Arm (2 arms). Primary endpoint: Mortality at 28 days. Started Oct 2015; status: completed.
02
Drugs
carvedilol
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT02583698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583698.